{
  "buckets": {
    "module": {
      "900000000000207008": 4
    },
    "semanticTags": {
      "disorder": 2
    },
    "language": {
      "en": 4
    },
    "membership": {
      "1322291000000109": 2,
      "1127601000000107": 2,
      "1382531000000102": 2,
      "999003161000000108": 2,
      "900000000000497000": 2,
      "733073007": 2,
      "999002271000000101": 2
    }
  },
  "languageNames": {
    "en": "english"
  },
  "bucketConcepts": {
    "1322291000000109": {
      "conceptId": "1322291000000109",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000041000000102",
      "fsn": {
        "term": "National Health Service Care Record Element association reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "NHS Care Record Element association reference set",
        "lang": "en"
      },
      "id": "1322291000000109"
    },
    "1127601000000107": {
      "conceptId": "1127601000000107",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Healthcare matters simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Healthcare matters simple reference set",
        "lang": "en"
      },
      "id": "1127601000000107"
    },
    "1382531000000102": {
      "conceptId": "1382531000000102",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Emergency care diagnosis max simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Emergency care diagnosis max simple reference set",
        "lang": "en"
      },
      "id": "1382531000000102"
    },
    "999003161000000108": {
      "conceptId": "999003161000000108",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set",
        "lang": "en"
      },
      "id": "999003161000000108"
    },
    "900000000000497000": {
      "conceptId": "900000000000497000",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "CTV3 to SNOMED CT simple map reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "CTV3 to SNOMED CT simple map",
        "lang": "en"
      },
      "id": "900000000000497000"
    },
    "733073007": {
      "conceptId": "733073007",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "OWL axiom reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "OWL axiom reference set",
        "lang": "en"
      },
      "id": "733073007"
    },
    "999002271000000101": {
      "conceptId": "999002271000000101",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000011000000103",
      "fsn": {
        "term": "International Classification of Diseases, Tenth Revision, Fifth Edition, five character code United Kingdom complex map reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "International Classification of Diseases, Tenth Revision, Fifth Edition, five character code United Kingdom complex map reference set",
        "lang": "en"
      },
      "id": "999002271000000101"
    },
    "900000000000207008": {
      "conceptId": "900000000000207008",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "SNOMED CT core module (core metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "SNOMED CT core",
        "lang": "en"
      },
      "id": "900000000000207008"
    }
  },
  "totalElements": 4,
  "totalPages": 1,
  "last": true,
  "numberOfElements": 4,
  "first": true,
  "size": 50,
  "number": 0,
  "items": [
    {
      "term": "A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective hematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "766046007",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor",
          "lang": "en"
        },
        "id": "766046007"
      }
    },
    {
      "term": "A subgroup of therapy-related myeloid neoplasms (t-MN), associated with treatment of an unrelated neoplastic disease with cytotoxic agents, like etoposide, doxorubicin, daunorubicin and others. The neoplastic cells often show rearrangements involving the mixed lineage leukaemia gene at 11q23. This subgroup of t-MN is typically associated with overt leukaemia, without preceding myelodysplastic syndrome, developing 2-3 years after exposure, presenting with non-specific symptoms related to ineffective haematopoesis (fatigue, bleeding and bruising, recurrent infections, bone pain) and/or extramedullary site involvement.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "766046007",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor",
          "lang": "en"
        },
        "id": "766046007"
      }
    },
    {
      "term": "A rare epithelial tumor of pancreas characterized by a solid, nodular mass growing within dilated pancreatic ducts, histologically composed of nodules of back-to-back tubular glands forming large cribriform structures, with high-grade dysplasia and ductal differentiation. There is no overt production of mucin. About half of the tumors occur in the head of the pancreas, one third involve the gland diffusely. Patients present with nonspecific symptoms including abdominal pain, vomiting, weight loss, steatorrhea, and diabetes mellitus, while obstructive jaundice is uncommon. This tumor type accounts for less than 1% of exocrine neoplasms and 3% of intraductal neoplasms of the pancreas.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1237341006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Intraductal tubulopapillary malignant neoplasm of pancreas (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Intraductal tubulopapillary malignant neoplasm of pancreas",
          "lang": "en"
        },
        "id": "1237341006"
      }
    },
    {
      "term": "A rare epithelial tumour of pancreas characterised by a solid, nodular mass growing within dilated pancreatic ducts, histologically composed of nodules of back-to-back tubular glands forming large cribriform structures, with high-grade dysplasia and ductal differentiation. There is no overt production of mucin. About half of the tumours occur in the head of the pancreas, one third involve the gland diffusely. Patients present with nonspecific symptoms including abdominal pain, vomiting, weight loss, steatorrhoea, and diabetes mellitus, while obstructive jaundice is uncommon. This tumour type accounts for less than 1% of exocrine neoplasms and 3% of intraductal neoplasms of the pancreas.",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "1237341006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Intraductal tubulopapillary malignant neoplasm of pancreas (disorder)",
          "lang": "en"
        },
        "pt": {
          "term": "Intraductal tubulopapillary malignant neoplasm of pancreas",
          "lang": "en"
        },
        "id": "1237341006"
      }
    }
  ]
}